Table 2.
treatment outcome following adverse drug reactions (ADRs)
HAART Regimen | Treatment changed (%) | Treatment maintained (%) | P-value |
---|---|---|---|
AZT-3TC-NVP | 6 (13.3) | 5 (23.8) | P=0.04 |
AZT-3TC-EFV | 7 (15.6) | 8 (38.1) | |
D4T-3TC-NVP | 24 (53.3) | 5 (23.8) | |
D4T-3TC-EFV | 7 (15.6) | 1 (4.8) | |
other | 1 (2.2) | 2 (9.5) | |
Total | 45 (68.2) | 21 (31.8) |
AZT: Zidovudine, D4T: Stavudine